Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets
Clinical trial NCT05295121 · COMPLETED
Trial details
- NCT number
- NCT05295121
- Sponsor
- Valenta Pharm JSC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-10
- Primary completion
- 2022-02-22
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.